Adverse Health Effects in People with and without Preexisting Respiratory Conditions during Bushfire Smoke Exposure in the 2019/2020 Australian Summer

Am J Respir Crit Care Med. 2021 Aug 1;204(3):368-371. doi: 10.1164/rccm.202012-4471LE.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Asthma / drug therapy
  • Asthma / physiopathology
  • Australia
  • Bronchiectasis / drug therapy
  • Bronchiectasis / physiopathology
  • Bronchitis, Chronic / drug therapy
  • Bronchitis, Chronic / physiopathology
  • Bronchodilator Agents / therapeutic use
  • Chronic Disease
  • Cross-Sectional Studies
  • Disease Progression*
  • Emergency Service, Hospital / statistics & numerical data*
  • Female
  • Glucocorticoids / therapeutic use
  • Hospitalization / statistics & numerical data*
  • Humans
  • Inhalation Exposure / adverse effects*
  • Lung Diseases / drug therapy
  • Lung Diseases / physiopathology*
  • Male
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / physiopathology
  • Pulmonary Emphysema / drug therapy
  • Pulmonary Emphysema / physiopathology
  • Smoke / adverse effects*
  • Wildfires*
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Bronchodilator Agents
  • Glucocorticoids
  • Smoke